Dynamic expression of matrix metalloproteinases 2, 9 and 13 in ovariectomy-induced osteoporosis rats

被引:38
作者
Zheng, Xuefeng [1 ]
Zhang, Yuanyuan [1 ]
Guo, Shiming [2 ]
Zhang, Wenming [3 ]
Wang, Jinyun [1 ]
Lin, Yanping [1 ]
机构
[1] Fujian Univ Tradit Chinese Med, Acupuncture Coll, 1 Qiuyang Rd, Fuzhou 350122, Fujian, Peoples R China
[2] Zhangzhou Hosp Tradit Chinese Med, Orthoped Dept, Zhangzhou 363000, Fujian, Peoples R China
[3] Luoyang Osteopathy Hosp, Orthoped Dept, Luoyang 471002, Henan, Peoples R China
基金
中国国家自然科学基金;
关键词
osteoporosis; bone resorption; MMP-2; MMP-9; MMP-13; BONE; MATRIX-METALLOPROTEINASE-2; OSTEOCLASTS; PHENOTYPE; CELLS; WOMEN; MMP-9; RISK;
D O I
10.3892/etm.2018.6356
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
100103 [病原生物学]; 100218 [急诊医学];
摘要
The aim of the present study was to examine the dynamic expression of matrix metalloproteinase (MMP)-2, MMP-9 and MMP-13 in an ovariectomy (OVX)-induced osteoporosis rat model. A total of 80 Sprague-Dawley female rats (age, 3 months) were randomly divided into the OVX and sham groups, with 40 rats in each group. Rats in the sham group received sham surgery, while the remaining rats were ovariectomized. After 12, 16, 20 and 24 weeks, 10 rats from each group were randomly sacrificed, respectively. It was observed that the bone mineral density (BMD) and the trabecular bone area in the OVX group were significantly lower as compared with those in the sham group (P<0.01). The expression levels of MMP-2 and MMP-9 were negatively correlated with the BMD, while MMP-13 was positively correlated with the BMD. The expression levels of MMP-2 and MMP-9 increased more abruptly and were significant higher in the OVX group in comparison with those in the sham group between 12 and 24 weeks after surgery (P<0.01). More specifically, the MMP-9 mRNA expression level in the OVX group increased abruptly between 12 and 24 weeks after surgery. By contrast, in the sham group, the MMP-9 mRNA level was undetectable between 12 and 16 weeks, and increased steadily between 16 and 24 weeks. Furthermore, the mRNA and protein expression levels of MMP-13 initially increased and then decreased in the OVX group (P<0.01 vs. the sham group), whereas they continuously increased in the sham group between 12 and 24 weeks after surgery. In conclusion, MMP-2, MMP-9 and MMP-13 regulated the development of osteoporosis, and MMP-9 may be used as an important marker in the early diagnosis of osteoporosis.
引用
收藏
页码:1807 / 1813
页数:7
相关论文
共 24 条
[1]
A scrutiny of matrix metalloproteinases in osteoclasts:: evidence for heterogeneity and for the presence of MMPs synthesized by other cells [J].
Andersen, TL ;
Ovejero, MD ;
Kirkegaard, T ;
Lenhard, T ;
Foged, NT ;
Delaissé, JM .
BONE, 2004, 35 (05) :1107-1119
[2]
Matrix metalloproteinases in cancer: comparison of known and novel aspects of their inhibition as a therapeutic approach [J].
Bachmeier, BE ;
Iancu, CM ;
Jochum, M ;
Nerlich, AG .
EXPERT REVIEW OF ANTICANCER THERAPY, 2005, 5 (01) :149-163
[3]
Animal models for fracture treatment in osteoporosis [J].
Egermann, Marcus ;
Goldhahn, J. ;
Schneider, E. .
OSTEOPOROSIS INTERNATIONAL, 2005, 16 (Suppl 2) :S129-S138
[4]
Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones [J].
Engsig, MT ;
Chen, QJ ;
Vu, TH ;
Pedersen, AC ;
Therkidsen, B ;
Lund, LR ;
Henriksen, K ;
Lenhard, T ;
Foged, NT ;
Werb, Z ;
Delaisse, JM .
JOURNAL OF CELL BIOLOGY, 2000, 151 (04) :879-889
[5]
The expression of metalloproteinase-2,-9, and-14 and of tissue inhibitors-1 and-2 is developmentally modulated during osteogenesis in vitro, the mature osteoblastic phenotype expressing metalloproteinase-14 [J].
Filanti, C ;
Dickson, GR ;
Di Martino, D ;
Ulivi, V ;
Sanguineti, C ;
Romano, P ;
Palermo, C ;
Manduca, P .
JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (11) :2154-2168
[6]
Hormone therapy for the prevention of bone loss in menopausal women with osteopenia - Is it a viable option? [J].
Hohenhaus, Mary H. ;
McGarry, Kelly A. ;
Col, Nananda F. .
DRUGS, 2007, 67 (16) :2311-2321
[7]
A crucial role for matrix metalloproteinase 2 in osteocytic canalicular formation and bone metabolism [J].
Inoue, Keiichi ;
Mikuni-Takagaki, Yuko ;
Oikawa, Kaoru ;
Itoh, Takeshi ;
Inada, Masaki ;
Noguchi, Takanori ;
Park, Jin-Sung ;
Onodera, Takashi ;
Krane, Stephen M. ;
Noda, Masaki ;
Itohara, Shigeyoshi .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (44) :33814-33824
[8]
Molecular Disease Map of Bone Characterizing the Postmenopausal Osteoporosis Phenotype [J].
Jemtland, Rune ;
Holden, Marit ;
Reppe, Sjur ;
Olstad, Ole K. ;
Reinholt, Finn P. ;
Gautvik, Vigdis T. ;
Refvem, Hilde ;
Frigessi, Arnoldo ;
Houston, Brian ;
Gautvik, Kaare M. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2011, 26 (08) :1793-1801
[9]
Diagnosis of osteoporosis and assessment of fracture risk [J].
Kanis, JA .
LANCET, 2002, 359 (9321) :1929-1936
[10]
Matrix metalloproteinases and bone [J].
Krane, Stephen M. ;
Inada, Masaki .
BONE, 2008, 43 (01) :7-18